# Gain Therapeutics, Inc.: Form 8-K, filed Jul 12, 2024

- Company: [Gain Therapeutics, Inc.](/companies/ganx.md) (CIK 1819411)
- Form: 8-K
- Filed: 2024-07-12
- Accepted by EDGAR: Jul 12, 2024, 17:24 ET
- Period: 2024-07-11
- Accession: 0001104659-24-079601
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1819411/000110465924079601/tm2419326d1_8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1819411/000110465924079601/

## Items reported

- Item 3.01: Delisting notice

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1819411/000110465924079601/tm2419326d1_8k.htm

Filed Jul 12, 2024.
Source: SEC EDGAR, the filing index for accession 0001104659-24-079601. Last ingested by Listed: Oct 30, 2026, 17:20 ET. No prices; not investment advice.